Coexistence of Life Threatening Chemotherapy Related Leukoencephalopathy, Saggital Sinus Thrombosis and Multiple Organ Failure in a Child with Acute Lymphoblastic Leukemia: An Unusual Case with Clinical Recovery

References

• Berg S.L., Poplack D.G. Complications of leukemia. Pediatr. Rew. 1991; 12: 313–319
   PubMedGoogle Scholar
• Niemeyer C.M., Sallan S.E. Acute lymphoblastic leukemia. Hematology of Infancy and Childhood4th ed., D. Nathan, F. Oski. WB Saunders, Philadelphia 1993; 1249–1287
   Google Scholar
• Rodman J.H., Relling M.V., Stewart C.S., et al. Clinical pharmacokinetics and pharmacodynamics of anticancer drugs in children. Seminars Oncol. 1993; 20: 18–29
   PubMed Web of Science ®Google Scholar
• Biti G.P., Magrini S.M., Villari N., et al. Brain damage after treatment for acute lymphoblastic leukemia. Acta Oncol. 1989; 28: 253–256
   PubMed Web of Science ®Google Scholar
• Ochs J.J. Neurotoxicity due to central nervous system therapy for childhood leukemia. Am J Pediatr Hematol/Oncol 1989; 11: 93–105
   PubMedGoogle Scholar
• Baker W.J., Royer G.L., Weiss R.B. Cytarabine and neurologic toxicity. J Clin Oncol 1991; 4: 679–693
   Google Scholar
• Feinberg W.M., Swenson M.R. Cerebrovascular complications of L-asparaginase therapy. Neurology 1988; 38: 127–133
   PubMed Web of Science ®Google Scholar
• Duru F., Akinci A., Ertem U., et al. Effect of L-asparaginase on glucose metabolism in children with acute lymphoblastic leukemia. Turkish J Cancer 1994; 24: 157–162
   Google Scholar
• Walsh D., Avashia J. Glucocorticoids in clinical oncology. Cleveland Clin J Med 1992; 59: 505–515
   PubMed Web of Science ®Google Scholar
• Jakacki R., Larsen R.L., Barber G., et al. Comparison of cardiac function tests after antracycline therapy in childhood. Cancer 1993; 72: 2739–2745
   PubMed Web of Science ®Google Scholar
• Silber J.H., Jakacki R., Larsen R.L., et al. Increased risk of cardiac dysfunction after antracyclines in girls. Med Pediart Oncol 1993; 21: 477–479
   PubMedGoogle Scholar
• Rivera G.K., Raimondi S.C., Hancock M.L., et al. Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination chemotherapy. Lancet 1991; 337: 61–46
   PubMed Web of Science ®Google Scholar
• Jolivet J., Cowan K.H., Curt G.A., et al. The pharmacology and clinical use of methotrexate. N Engl J Med 1983; 309: 1094–1102
   PubMed Web of Science ®Google Scholar
• Price R.A., Jamieson P.A. The central nervous system in childhood leukemia. Cancer 1975; 35: 306–318
   PubMed Web of Science ®Google Scholar
• Gagliano R.G., Costanzi J.J. Paraplegia following intrathecal methotrexate. Report of a case and review of the literature. Cancer 1976; 37: 1663–1668
   PubMed Web of Science ®Google Scholar
• Ilhan I., Cila A., Büyükpamukcu M., et al. Methotrexate induced leukoencephalopathy, A case report. Turkish J Pediatr 1995; 37: 275–278
   PubMed Web of Science ®Google Scholar
• Rubinstein L.J., Herman M.M., Long T.F., Wilbur J.R. Disseminated necrotizing leukoencephalopathy: A complication of treated central nervous system leukemia and lymphoma. Cancer 1975; 35: 291–305
   PubMed Web of Science ®Google Scholar
• Kingma A., Mooyaart E.L., Kamps W.A., et al. Magnetic resonance imaging of the brain and neuropsycological evaluation in children treated for acute lymphoblastic leukemia at a young age. Am J Pediatr Hematol/Oncol 1993; 15: 231–238
   PubMedGoogle Scholar
• Asato R., Akiyama Y., Ito M., et al. Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intracranial methotrexate. Cancer 1992; 70: 1991–2004
   Web of Science ®Google Scholar
• Leone G., Gugliotta L., Mazzucconi M.G., et al. Evidence of hypercoagulable state in patients with acute lymphoblastic leukemia treated with low dose of E. coli L-asparaginase: A GIMEMA Study. Thromb Haemostas 1993; 69: 12–15
   PubMed Web of Science ®Google Scholar
• Semeraro N., Montemuno P., Giordano P., et al. Unbalanced coagulation-fibrinolysis potential during L-asparaginase therapy in children with acute lymphoblastic leukemia. Thromb Haemostas 1990; 64: 38–40
   PubMed Web of Science ®Google Scholar
• Bleyer W.A., Drake J.C., Chabner B.A. Neurotoxicity and elevated cerebrospinal fluid methotrexate concentration in meningeal leukemia. N Engl J Med 1973; 289: 110–113
   PubMed Web of Science ®Google Scholar
• Lauer S.J., Kirchner P.A. Identification of leukemic cells in the cerebrospinal fluid from children with acute leukemia: advances and dilemmas. Am J Pediatr Hematol/ Oncol 1989; 11: 64–72
   PubMedGoogle Scholar
• Steinherz P.G. Transient severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase. Cancer 1994; 74: 3234–3239
   PubMed Web of Science ®Google Scholar